灌注受损与症状性颅内动脉粥样硬化早期缺血性卒中复发:BIORISK ICAS研究
BIORISK ICAS为多中心回顾性国际研究,纳入2050例症状性ICAS患者,评估远端灌注受损生物标志物与90天内复发缺血性卒中的关联。主要分析纳入1891例,174例(9.2%)复发;前循环边缘带梗死与复发相关(aHR 1.40,95%CI 1.02-1.93)。灌注成像亚组中,低灌注错配≥10 mL与复发相关(aHR 1.83,95%CI 1.03-3.28)。
要点
- 症状性ICAS患者90天内复发缺血性卒中比例为9.2%。
- 前循环边缘带梗死与90天复发独立相关(aHR 1.40)。
- 低灌注错配≥10 mL与复发相关(aHR 1.83)。
核心结论
- 远端灌注受损生物标志物(前循环边缘带梗死和低灌注错配)与症状性ICAS患者90天内复发缺血性卒中风险增加相关。
- 研究结果支持在ICAS中使用灌注成像,并为未来在高风险ICAS患者中开展早期再灌注试验提供依据。
研究设计与样本
- BIORISK ICAS为多中心回顾性国际研究,共35个中心,纳入2019年1月至2024年6月住院的症状性ICAS患者(颅内椎动脉、基底动脉、远端颈内动脉或大脑中动脉近端50%-99%狭窄)。
- 主要分析纳入1891例患者,暴露为急性前循环边缘带梗死;次要分析纳入发病72小时内且完成灌注成像的亚组,暴露为Tmax 6秒阈值低灌注错配体积(按Youden指数二分类)。
- 主要结局为90天内症状性动脉供血区复发缺血性卒中,采用多变量Cox回归调整临床相关变量及与结局相关变量(P<0.1)。
主要发现
- 2050例症状性ICAS患者中,1737例(84.7%)在症状发作72小时内就诊,其中509例(29.3%)接受灌注成像。
- 主要分析中174例(9.2%)出现症状性动脉供血区复发缺血性卒中。
- 调整后Cox回归显示,前循环边缘带梗死与90天复发缺血性卒中相关(aHR 1.40,95%CI 1.02-1.93)。
- 灌注成像分析中,低灌注错配≥10 mL与复发缺血性卒中相关(aHR 1.83,95%CI 1.03-3.28)。
临床怎么用
- 对症状性ICAS患者,可考虑使用灌注成像评估远端灌注受损情况以辅助风险分层。
- 前循环边缘带梗死或低灌注错配≥10 mL提示90天内复发缺血性卒中风险较高。
局限性
- 本研究为回顾性研究设计。
- 灌注成像分析仅纳入完成灌注成像的亚组患者(509例),样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracranial atherosclerosis (ICAS) is associated with an increased risk of early recurrent ischemic stroke. We evaluated whether biomarkers of impaired distal perfusion-specifically, anterior circulation borderzone infarct, and hypoperfusion mismatch volume-were associated with recurrent ischemic stroke within 90 days. METHODS: The BIORISK ICAS (Biomarkers and Recurrence Risk in Symptomatic Intracranial Atherosclerosis) is a multicenter retrospective international study (35 sites) that included hospitalized patients with symptomatic ICAS (50%-99% luminal stenosis of the intracranial vertebral, basilar, distal internal carotid, or proximal middle cerebral artery) from January 2019 to June 2024. The primary outcome was recurrent ischemic stroke in the territory of the symptomatic artery within 90 days. In the primary analysis, the exposure was an acute anterior circulation borderzone infarct. In secondary analysis of the subset with presentation within 72 hours of last known normal and perfusion imaging completed, the exposure of interest was prespecified as hypoperfusion mismatch volume at Tmax (time to maximum) threshold of 6 seconds, dichotomized at the Youden index. We performed multivariable Cox regression to test associations between exposure variables and the outcome, adjusting for clinically relevant variables and those associated with the outcome (P<0.1). RESULTS: Of 2050 patients with symptomatic ICAS, 1737 (84.7%) presented within 72 hours of symptom onset, among whom 509 (29.3%) underwent perfusion imaging. The primary analysis included 1891 patients; 174 (9.2%) patients had recurrent ischemic stroke in the symptomatic arterial territory. In adjusted Cox regression models, there was an association between anterior circulation borderzone infarct and recurrent ischemic stroke at 90 days (adjusted hazard ratio, 1.40 [95% CI, 1.02-1.93]). In the perfusion imaging analysis, hypoperfusion mismatch of ≥10 mL was associated with recurrent ischemic stroke (adjusted hazard ratio, 1.83 [95% CI, 1.03-3.28]). CONCLUSIONS: Biomarkers of impaired distal perfusion, anterior circulation borderzone infarct, and hypoperfusion mismatch were associated with increased risk of recurrent ischemic stroke. These findings support the use of perfusion imaging in ICAS as well as future trials investigating early reperfusion in high-risk patients with ICAS.
引用
- Yaghi S, Khan F, Lewis S, et al. Impaired Perfusion and Early Ischemic Stroke Recurrence in Symptomatic Intracranial Atherosclerosis: BIORISK ICAS Study. Stroke. 2025. PMID: 41128719. doi:10.1161/STROKEAHA.125.053160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。